204 related articles for article (PubMed ID: 9784018)
1. Impact of CYP2E1 genotype in renal cell and urothelial cancer patients.
Farker K; Lehmann MH; Oelschlägel B; Haerting J; Hoffmann A; Janitzky V; Schubert J
Exp Toxicol Pathol; 1998 Sep; 50(4-6):425-31. PubMed ID: 9784018
[TBL] [Abstract][Full Text] [Related]
2. CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations.
Farker K; Lehmann MH; Kästner R; Hoffmann A; Janitzky V; Schubert J; Matz U; Hofmann W
Int J Clin Pharmacol Ther; 1998 Sep; 36(9):463-8. PubMed ID: 9760005
[TBL] [Abstract][Full Text] [Related]
3. Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huai'an population, China.
Liu R; Yin LH; Pu YP
Chin Med J (Engl); 2007 Oct; 120(20):1797-802. PubMed ID: 18028774
[TBL] [Abstract][Full Text] [Related]
4. Genetic repeat polymorphism in the regulating region of CYP2E1: frequency and relationship with enzymatic activity in alcoholics.
Plee-Gautier E; Foresto F; Ferrara R; Bodénez P; Simon B; Manno M; Berthou F; Lucas D
Alcohol Clin Exp Res; 2001 Jun; 25(6):800-4. PubMed ID: 11410713
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of cytochrome P450 2E1 RsaI/PstI and DraI polymorphisms in workers exposed to benzene].
Chen Z; Ling J; Liu Y; Wu X; Wang D; Wang J; Tu H
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2015 Aug; 33(8):595-7. PubMed ID: 26653810
[TBL] [Abstract][Full Text] [Related]
6. Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer.
Feng J; Pan X; Yu J; Chen Z; Xu H; El-Rifai W; Zhang G; Xu Z
PLoS One; 2012; 7(9):e44478. PubMed ID: 22957075
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan.
Wu MS; Chen CJ; Lin MT; Wang HP; Shun CT; Sheu JC; Lin JT
Int J Colorectal Dis; 2002 Sep; 17(5):338-43. PubMed ID: 12172927
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1.
Lin DX; Tang YM; Peng Q; Lu SX; Ambrosone CB; Kadlubar FF
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1013-8. PubMed ID: 9829710
[TBL] [Abstract][Full Text] [Related]
9. Association between CYP2E1 genetic polymorphisms and lung cancer risk: a meta-analysis.
Wang Y; Yang H; Li L; Wang H; Zhang C; Yin G; Zhu B
Eur J Cancer; 2010 Mar; 46(4):758-64. PubMed ID: 20031389
[TBL] [Abstract][Full Text] [Related]
10. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China.
Tan W; Song N; Wang GQ; Liu Q; Tang HJ; Kadlubar FF; Lin DX
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):551-6. PubMed ID: 10868687
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil: case-control studies of Japanese Brazilians and non-Japanese Brazilians.
Nishimoto IN; Hanaoka T; Sugimura H; Nagura K; Ihara M; Li XJ; Arai T; Hamada GS; Kowalski LP; Tsugane S
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):675-80. PubMed ID: 10919737
[TBL] [Abstract][Full Text] [Related]
12. The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies.
Tang K; Li Y; Zhang Z; Gu Y; Xiong Y; Feng G; He L; Qin S
BMC Cancer; 2010 Oct; 10():575. PubMed ID: 20969746
[TBL] [Abstract][Full Text] [Related]
13. Functional RsaI/PstI polymorphism in cytochrome P450 2E1 contributes to bladder cancer susceptibility: evidence from a meta-analysis.
Deng XD; Gao Q; Zhang B; Zhang LX; Zhang W; Mu Er ZE; Xie Y; Ma Y; Liu Y
Asian Pac J Cancer Prev; 2014; 15(12):4977-82. PubMed ID: 24998574
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants of the cytochrome P450 and glutathione S-transferase associated with risk of bladder cancer in a south-eastern Chinese population.
Shao J; Gu M; Zhang Z; Xu Z; Hu Q; Qian L
Int J Urol; 2008 Mar; 15(3):216-21. PubMed ID: 18304215
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism of cytochrome P450 2E1 in the Turkish population.
Omer B; Ozbek U; Akköse A; Kiliç G
Cell Biochem Funct; 2001 Dec; 19(4):273-5. PubMed ID: 11746208
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of ADH1C and CYP2E1 and risk of oral squamous cell carcinoma.
Brocic M; Supic G; Zeljic K; Jovic N; Kozomara R; Zagorac S; Zlatkovic M; Magic Z
Otolaryngol Head Neck Surg; 2011 Oct; 145(4):586-93. PubMed ID: 21705789
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk.
Kato S; Shields PG; Caporaso NE; Hoover RN; Trump BF; Sugimura H; Weston A; Harris CC
Cancer Res; 1992 Dec; 52(23):6712-5. PubMed ID: 1423319
[TBL] [Abstract][Full Text] [Related]
18. CYP2E1 RsaI and 96-bp insertion genetic polymorphisms associated with risk for colorectal cancer.
Silva TD; Felipe AV; Pimenta CA; Barão K; Forones NM
Genet Mol Res; 2012 Sep; 11(3):3138-45. PubMed ID: 23007992
[TBL] [Abstract][Full Text] [Related]
19. A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma.
Wang YH; Yeh SD; Shen KH; Shen CH; Juang GD; Hsu LI; Chiou HY; Chen CJ
Toxicol Appl Pharmacol; 2009 Nov; 241(1):111-8. PubMed ID: 19686770
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 2E1 RsaI/PstI and DraI Polymorphisms Are Risk Factors for Lung Cancer in Mongolian and Han Population in Inner Mongolia.
Su XL; Bin B; Cui HW; Ran MR
Chin J Cancer Res; 2011 Jun; 23(2):107-11. PubMed ID: 23483202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
